Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Penicillin G potassium is a natural penicillin antibiotic belonging to the β-lactam class. It works by killing bacteria that cause infections, primarily by inhibiting bacterial cell wall synthesis. It comes as a powder to be mixed with water or as a premixed product for injection. It is used to treat and prevent certain infections caused by susceptible strains of bacteria. Chemically, Penicillin G potassium is monopotassium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate. It has a molecular weight of 372.48.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Penicillin G potassium.